Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Moreau

Showing results (101-110 of 160) with videos related to

Pageof 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2012
Clinical impact of NOTCH1 and/or FBXW7 mutations, FLASH deletion, and TCR status in pediatric T-cell lymphoblastic lymphomaCeline Callens, Frederic Baleydier, Etienne Lengline, et al.
Journal of the American Society of Nephrology : JASN|July 15, 2005
Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantationMaryvonne Hourmant, Anne Cesbron-Gautier, Paul I Terasaki, et al.
Blood|October 5, 2016
Rational targeted therapies to overcome microenvironment-dependent expansion of mantle cell lymphomaDavid Chiron, Céline Bellanger, Antonin Papin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 2018
Breakdown of Immune Tolerance in AIRE-Deficient Rats Induces a Severe Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy-like Autoimmune DiseaseJason Ossart, Anne Moreau, Elodie Autrusseau, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2008
Implication of matrix metalloproteinase 7 and the noncanonical wingless-type signaling pathway in a model of kidney allograft tolerance induced by the administration of anti-donor class II antibodiesVojislav Jovanovic, Anne-Sophie Dugast, Jean-Marie Heslan, et al.
The Journal of Clinical Investigation|February 15, 2022
Anti-CD45RC antibody immunotherapy prevents and treats experimental autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndromeMarine Besnard, Céline Sérazin, Jason Ossart, et al.
Leukemia & Lymphoma|June 30, 2010
Reduced-intensity conditioning allogeneic stem cell transplant for relapsed or transformed aggressive B-cell non-Hodgkin lymphomaAline Clavert, Steven Le Gouill, Eolia Brissot, et al.
The American Journal of Surgical Pathology|May 12, 2023
Giant Cell Tumors With HMGA2::NCOR2 Fusion : Clinicopathologic, Molecular, and Epigenetic Study of a Distinct EntityRaul Perret, Zaki Malaka, Valérie Velasco, et al.
Haematologica|August 3, 2019
Prognostic value of FDG-PET in patients with mantle cell lymphoma: results from the LyMa-PET ProjectClément Bailly, Thomas Carlier, Alina Berriolo-Riedinger, et al.
Hematological Oncology|January 19, 2020
Clinical characteristics and outcomes of relapsed follicular lymphoma after autologous stem cell transplantation in the rituximab eraPierre Sesques, Jessie Bourcier, Camille Golfier, et al.
Pageof 16

Showing results (101-110 of 160) with videos related to

Sort By:
Pageof 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2012
Clinical impact of NOTCH1 and/or FBXW7 mutations, FLASH deletion, and TCR status in pediatric T-cell lymphoblastic lymphomaCeline Callens, Frederic Baleydier, Etienne Lengline, et al.
Journal of the American Society of Nephrology : JASN|July 15, 2005
Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantationMaryvonne Hourmant, Anne Cesbron-Gautier, Paul I Terasaki, et al.
Blood|October 5, 2016
Rational targeted therapies to overcome microenvironment-dependent expansion of mantle cell lymphomaDavid Chiron, Céline Bellanger, Antonin Papin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 2018
Breakdown of Immune Tolerance in AIRE-Deficient Rats Induces a Severe Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy-like Autoimmune DiseaseJason Ossart, Anne Moreau, Elodie Autrusseau, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2008
Implication of matrix metalloproteinase 7 and the noncanonical wingless-type signaling pathway in a model of kidney allograft tolerance induced by the administration of anti-donor class II antibodiesVojislav Jovanovic, Anne-Sophie Dugast, Jean-Marie Heslan, et al.
The Journal of Clinical Investigation|February 15, 2022
Anti-CD45RC antibody immunotherapy prevents and treats experimental autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndromeMarine Besnard, Céline Sérazin, Jason Ossart, et al.
Leukemia & Lymphoma|June 30, 2010
Reduced-intensity conditioning allogeneic stem cell transplant for relapsed or transformed aggressive B-cell non-Hodgkin lymphomaAline Clavert, Steven Le Gouill, Eolia Brissot, et al.
The American Journal of Surgical Pathology|May 12, 2023
Giant Cell Tumors With HMGA2::NCOR2 Fusion : Clinicopathologic, Molecular, and Epigenetic Study of a Distinct EntityRaul Perret, Zaki Malaka, Valérie Velasco, et al.
Haematologica|August 3, 2019
Prognostic value of FDG-PET in patients with mantle cell lymphoma: results from the LyMa-PET ProjectClément Bailly, Thomas Carlier, Alina Berriolo-Riedinger, et al.
Hematological Oncology|January 19, 2020
Clinical characteristics and outcomes of relapsed follicular lymphoma after autologous stem cell transplantation in the rituximab eraPierre Sesques, Jessie Bourcier, Camille Golfier, et al.
Pageof 16